Tissue factor-dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 12, 2007, Pages 2415-2420

  Boer, K ^a   Den Hollander, I A ^a   Meijers, J C M ^a   Levi, Marcel ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Blood coagulation factors; Labor; Obstetric; Postpartum period; Thromboplastin; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 7A; NADROPARIN; OXYTOCIN; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TIME; CANNULA; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS DISTRESS; HUMAN; LABOR INDUCTION; PLACENTA; PRIORITY JOURNAL; PUERPERIUM; RADICULOPATHY; THROMBIN TIME; VAGINAL DELIVERY; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTITHROMBIN III; BLOOD COAGULATION; CESAREAN SECTION; FACTOR VIIA; FEMALE; GESTATIONAL AGE; HUMANS; LABOR, INDUCED; LABOR, OBSTETRIC; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTHROMBIN; RISK FACTORS; THROMBIN; THROMBOPLASTIN; TIME FACTORS; UP-REGULATION; VENOUS THROMBOEMBOLISM;

EID: 36348980450     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02767.x     Document Type: Article

References (35)

1. Hellgren, M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29:125-30.
2. James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol 2005; 193:216-9.
3. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study. Ann Intern Med 2005; 143:697-706.
4. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Path 1989; 134:1087-97.
5. Fleck RA, Rao LV, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 57:765-81.
6. Ehrlich J, Parry GCN, Fearns C, Muller M, Carmeliet P, Luther T, Mackman N. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci USA 1999; 96:8138-43.
7. Sandset PM, Abildgaard U, Pettersen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 1987; 47:389-400.
8. Hemker HC, Willems GM, Beguin S. A computer-assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56:9-17.
9. Nicolaes GA, Thomassen MC, Tans G. Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals. Blood Coagul Fibrinolysis 1997; 8:28-38.
10. de Pont AC, Bakthiari K, Hutten BA, de Jonge E, Vlasuk GP, Rote WE, Levi M, Büller HR, Meijers JC. Endotoxaemia induces resistance to activated protein C in healthy humans. Br J Haematol 2006; 134:213-9.
11. Marsik C, Quehenberger P, Mackman N, Osterud B, Jilma B. Validation of a novel tissue factor assay in experimental human endotoxemia. Thromb Res 2003; 111:311-5.
12. Gabbe SG. Obstetrics - Normal and Problem Pregnancies, 4th edn. London: Churchill Livingstone, Inc., 2002.
13. Greer IA. Thrombosis in pregnancy: Maternal and fetal issues. Lancet 1999; 353:1258-65.
14. Franchini M. Haemostasis and pregnancy. Thromb Haemost 2006; 95:401-13.
15. Masuda J, Takayama E, Satoh A, Ida M, Shinohara T, Kojima-Aikawa K, Ohsuzu F, Nakanishi K, Kuroda K, Murakami M, Suzuki K, Matsumoto I. Levels of annexin IV and V in the plasma of pregnant and postpartum women. Thromb Haemost 2004; 91:1129-36.
16. Albrecht S, Muller S, Siegert G, Luther T, Muller M. Plasma concentration of tissue factor and factor VII in patients after abdominal surgery. Thromb Res 1995; 77:557-62.
17. Uszynski M, Zekanowska E, Uszynski W. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol 2001; 95:163-6.
18. Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 1996; 88:881-6.
19. Pawlinski R, Mackman N. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med 2004; 32:S293-7.
20. Kondo S, Noguchi M, Funakoshi T. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein. Thromb Res 1987; 48:449-59.
21. Krikun G, Lockwood CJ, Wu XX, Zhou XD, Guller S, Calandri C, Guha A, Nemerson Y, Rand JH. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: Immunolocalization and regulation. Placenta 1994; 15:601-12.
22. Ravassa S, Bennaghmouch A, Kenis H, Lindhout T, Hackeng T, Narula J, Hofstra L, Reutelingsperger C. Annexin A5 down-regulates surface expression of tissue factor: A novel mechanism of regulating the membrane receptor repertoir. J Biol Chem 2005; 280:6028-35.
23. Kolialexi A, Tsangaris GT, Anagnostopoulos A, Chondros D, Bagiokos V, Kitsiou S, Kanavakis E, Mavrou A. Two-way trafficking of Annexin V positive cells between mother and fetus: Determination of apoptosis at delivery. Prenat Diagn 2007; 27:348-51.
24. Kolialexi A, Tsangaris GT, Antsaklis A, Mavroua A. Rapid clearance of fetal cells from maternal circulation after delivery. Ann N Y Acad Sci 2004; 1022:113-8.
25. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-92.
26. Weiner CP. The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 1986; 13:705-17.
27. Butenas S, Mann KG. Blood coagulation. Biochemistry (Moscow) 2002; 67:5-15.
28. Versteeg HH, Peppelenbosch MP, Spek CA. The pleiotropic effects of tissue factor: A possible role for factor VIIa-induced intracellular signalling? Thromb Haemost 2001; 86:592-3.
29. Norris LA. Blood coagulation. Best Pract Res Clin Obstet Gynaecol 2003; 17:369-83.
30. Tilley R, Mackman N. Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost 2006; 32:5-10.
31. Melis E, Moons L, de Mol M, Herbert JM, Mackman N, Collen D, Carmeliet P, Dewerchin M. Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development. Biochem Biophys 2001; 286:580-6.
32. Melis E, Moons L, Arnout J, Hoylaerts MF, Collen D, Carmeliet P, Dewerchin M. Thrombophilia in mice expressing a tissue factor variant lacking its transmembrane and cytosolic domain. Biochem Biophys 2005; 333:488-95.
33. Sandset PM, Bendz B, Hansen JB. Physiological function of tissue factor pathway inhibitor and interaction with heparins. Haemostasis 2000; 30:48-56.
34. Ellison J, Thomson AJ, Conkie JA, McCall F, Walker D, Greer A. Thromboprophylaxis following cesarean section. A comparison of the antithrombotic properties of three low molecular weight heparins - dalteparin, enoxaparin and tinzaparin. Thromb Haemost 2001; 86:1374-8.
35. Romero A, Alonso C, Rincón M, Medrano J, Santos JM, Calderon E, Marin I, Gonzalez MA. Risk of venous thromboembolic disease in women. A qualitative systematic review. Eur J Obstet Gynecol Reprod Biol 2005; 121:8-17.